ctrl K

Price Alert

Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

7.12

-0.11 (-1.52%)

At close: Aug 15, 2025, 3:59 PM

7.27

2.10%

After-hours: Aug 15, 2025, 05:39 PM EDT

Abeona Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	23.36M	14.47M	14.22M	32.94M
Short-Term Investments	74.36M	37.75M	37.93M	12.09M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	96K	277K	43K	168K
Receivables	1.65M	2.44M	188K	3M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.48M	338K	424K	891K
Total Current Assets	100.85M	55.74M	53.1M	56.29M
Property-Plant & Equipment	7.98M	7.99M	11.07M	21.74M
Goodwill & Intangibles	n/a	n/a	n/a	1.38M
Total Long-Term Assets	8.08M	8.27M	11.12M	23.29M
Total Assets	108.93M	64M	64.21M	79.59M
Account Payables	3.44M	1.86M	1.81M	4.33M
Deferred Revenue	n/a	n/a	n/a	296K
Short-Term Debt	5.93M	n/a	n/a	n/a
Other Current Liabilities	4.46M	3.69M	1.6M	1.79M
Total Current Liabilities	16.59M	13.42M	7.78M	16.62M
Long-Term Debt	13.04M	n/a	n/a	n/a
Other Long-Term Liabilities	32.01M	31.35M	23.82M	13.04M
Total Long-Term Liabilities	48.31M	35.75M	29.67M	20.59M
Total Liabilities	64.9M	49.18M	37.45M	37.22M
Total Debt	23.05M	5.4M	7.63M	9.38M
Common Stock	457K	265K	177K	1.47M
Retained Earnings	-813.26M	-749.52M	-695.34M	-655.64M
Comprehensive Income	8K	-66K	-129K	-27K
Shareholders Equity	44.03M	14.83M	26.76M	42.37M
Total Investments	74.36M	37.75M	37.93M	12.09M